Supply of the drug Adalimumab, solution for subcutaneous administration, 40 mg / 0.4 ml, 0.4 ml and / or 40 mg / 0.8 ml, & # xD; 0.8 ml, and / or 100 mg / ml, 0.4 ml in the framework of the implementation of the Decree of the Government of the Russian Federation dated November 26, 2018 No. 1416 “On the procedure for organizing the provision of medicines to persons with hemophilia, cystic fibrosis, & # xD; pituitary dwarfism, Gaucher's disease, malignant neoplasms of lymphoid, hematopoietic and related tissues, multiple sclerosis, hemolytic uremic syndrome, juvenile arthritis with systemic onset, & # xD; mucopolysaccharidosis types I, II and VI, unspecified aplastic anemia, hereditary deficiency of factors II (fibrinogen), VII (labile), X (Stuart-Prower), persons after organ and (or) tissue transplantation, as well as o & # xD;

This tender with title Supply of the drug Adalimumab, solution for subcutaneous administration, 40 mg / 0.4 ml, 0.4 ml and / or 40 mg / 0.8 ml, & # xD; 0.8 ml, and / or 100 mg / ml, 0.4 ml in the framework of the implementation of the Decree of the Government of the Russian Federation dated November 26, 2018 No. 1416 “On the procedure for organizing the provision of medicines to persons with hemophilia, cystic fibrosis, & # xD; pituitary dwarfism, Gaucher's disease, malignant neoplasms of lymphoid, hematopoietic and related tissues, multiple sclerosis, hemolytic uremic syndrome, juvenile arthritis with systemic onset, & # xD; mucopolysaccharidosis types I, II and VI, unspecified aplastic anemia, hereditary deficiency of factors II (fibrinogen), VII (labile), X (Stuart-Prower), persons after organ and (or) tissue transplantation, as well as o & # xD; -- Поставка лекарственного препарата Адалимумаб, раствор для подкожного введения, 40 мг/0,4 мл, 0,4 мл и/или 40 мг/0,8 мл, 0,8 мл, и/или 100 мг/мл, 0,4 мл в рамках реализации постановления Правительства Российской Федерации от26.11.2018 №1416 «О порядке организации обеспечения лекарственными препаратами лиц, больных гемофилией, муковисцидозом, гипофизарным нанизмом, болезнью Гоше, злокачественными новообразованиями лимфоидной, кроветворной и родственных им тканей, рассеянным склерозом, гемолитико-уремическим синдромом, юношеским артритом с системным началом, мукополисахаридозом I, II и VI типов, апластической анемией неуточненной, наследственным дефицитом факторов II (фибриногена), VII (лабильного), X (Стюарта - Прауэра), лиц после трансплантации органов и (или) тканей, а также о признании утратившими силу некоторых актов Правительства Российской Федерации» has been published on Bidding Source portal dated 22 Dec 2020 for the country of Russia. It has been categorized on Planting and maintenance services of green areas & Pharmaceutical products & Pituitary, hypothalamic hormones and analogues. For similar tenders you can see tenders mentioned below of this page.